Form 4: OptimizeRx Officer Converts RSUs, Sells Shares for Tax

OptimizeRx Chief Product & Tech Officer Doug Besch converted restricted stock units into common stock and subsequently sold a portion to cover tax obligations.

Summary

• Doug Besch, Chief Product & Tech Officer of OptimizeRx Corp (OPRX), acquired 3,325 shares of common stock on October 3, 2025, through the conversion of restricted stock units (RSUs).
• These RSUs converted into common stock on a one-for-one basis at an exercise price of $0.
• Following the RSU conversion, Mr. Besch disposed of 983 shares of common stock at a price of $18.75 per share to satisfy tax withholding obligations.
• The restricted stock units vest in three equal annual installments, with the first installment beginning October 3, 2023, the first anniversary of the grant date.
• After these transactions, Mr. Besch's direct beneficial ownership of OptimizeRx common stock stands at 69,572 shares.

Sentiment

Score: 5

Explanation: The transaction represents a routine vesting and tax-related disposition of shares by an insider, which is a common occurrence and does not inherently signal positive or negative company performance or a change in fundamental outlook.

Positives

• The conversion of Restricted Stock Units (RSUs) indicates the vesting of previously granted equity compensation, which is a positive event for the reporting person.
• The transaction reflects a standard compensation practice, aligning executive incentives with shareholder value over time.

Negatives

• The disposition of 983 shares reduces the reporting person's direct beneficial ownership in the company, although it was for tax withholding purposes.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This insider transaction is a routine event common across all publicly traded companies, reflecting the standard process of executive equity compensation vesting and tax management. It does not provide specific insights into broader industry trends.

Related Party Transactions

• The disposition of 983 shares was made to the issuer (OptimizeRx Corp) to satisfy the reporting person's tax withholding obligations related to the RSU conversion.

Stakeholder Impact

• Shareholders: Minimal impact, as the transaction is a routine part of executive compensation and tax management, not indicative of a change in company fundamentals.
• Employees: The vesting of RSUs demonstrates the company's commitment to its equity compensation plans for key personnel.

Key Dates

Recommendation

This Form 4 details a routine insider transaction involving the vesting and conversion of restricted stock units, followed by a sale of shares to cover tax obligations. Such transactions are common and do not typically indicate a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing.

Keywords

OptimizeRx, OPRX, Insider Transaction, Form 4, Restricted Stock Units, RSU Conversion, Tax Withholding, Equity Compensation